These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17668865)

  • 1. Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system.
    van de Glind G; de Graaf S; Klein C; Cornelissen M; Maecker B; Loeffen J
    Pediatr Blood Cancer; 2008 Apr; 50(4):886-8. PubMed ID: 17668865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained response to intrathecal rituximab in EBV associated Post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant.
    Bonney DK; Htwe EE; Turner A; Kelsey A; Shabani A; Hughes S; Hughes I; Wynn RF
    Pediatr Blood Cancer; 2012 Mar; 58(3):459-61. PubMed ID: 21584931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation.
    Twombley K; Pokala H; Ardura MI; Harker-Murray P; Johnson-Welch SF; Weinberg A; Seikaly M
    Pediatr Transplant; 2012 Sep; 16(6):E201-9. PubMed ID: 22646132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of rituximab concentration in the cerebrospinal fluid in CNS lymphoma].
    Kikuchi A; Kawada H; Iwaki Y; Machida S; Tsuchiya T; Fukuda R; Hotta T
    Rinsho Ketsueki; 2004 Dec; 45(12):1255-7. PubMed ID: 15678918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-associated lymphoproliferative disorder presenting as apparently isolated gastrointestinal lesions in childhood.
    Sebire NJ; Malone M; Risdon RA; Ramsay AD
    Pediatr Dev Pathol; 2005; 8(1):88-91. PubMed ID: 15717118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation.
    Higuchi M; Hata T; Furuya S; Hosaka S; Kamijo Y; Kiyosawa K; Ishizuka O; Nishizawa O; Hora K
    Nephrology (Carlton); 2005 Jun; 10(3):321-4. PubMed ID: 15958050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD; Hunger SP; Braylan RC; Dharnidharka VR
    Transpl Infect Dis; 2008 Dec; 10(6):426-30. PubMed ID: 18657087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of EBV PTLD with CNS lymphomas with the monoclonal anti-CD20 antibody rituximab.
    Kordelas L; Trenschel R; Koldehoff M; Elmaagacli A; Beelen DW
    Onkologie; 2008 Dec; 31(12):691-3. PubMed ID: 19060508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma.
    Sirvent-Von Bueltzingsloewen A; Sirvent N; Morand P; Cassuto JP
    Med Pediatr Oncol; 2003 Jun; 40(6):408-9. PubMed ID: 12692818
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphomatoid granulomatosis involving central nervous system successfully treated with rituximab alone.
    Ishiura H; Morikawa M; Hamada M; Watanabe T; Kako S; Chiba S; Motokura T; Hangaishi A; Shibahara J; Akahane M; Goto J; Kwak S; Kurokawa M; Tsuji S
    Arch Neurol; 2008 May; 65(5):662-5. PubMed ID: 18474745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with rituximab for autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus and monoclonal gammopathy in a post-nonmyeloablative stem cell transplant patient.
    Endo T; Nakao S; Koizumi K; Nishio M; Fujimoto K; Sakai T; Kumano K; Obara M; Koike T
    Ann Hematol; 2004 Feb; 83(2):114-6. PubMed ID: 14513283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
    Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
    Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
    Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ
    Transpl Int; 2007 Mar; 20(3):207-18. PubMed ID: 17291214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir].
    Hansen PB; Al-Farra G
    Ugeskr Laeger; 2010 Oct; 172(42):2907-8. PubMed ID: 21040668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.
    Garceau P; Couture C; Cantin B; Bernier V; Sénéchal M
    J Heart Lung Transplant; 2008 Aug; 27(8):928-31. PubMed ID: 18656811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.
    Mineo JF; Scheffer A; Karkoutly C; Nouvel L; Kerdraon O; Trauet J; Bordron A; Dessaint JP; Labalette M; Berthou C; Labalette P
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4738-45. PubMed ID: 18552383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
    Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraventricular treatment of relapsed central nervous system lymphoma with the anti-CD20 antibody rituximab.
    Schulz H; Pels H; Schmidt-Wolf I; Zeelen U; Germing U; Engert A
    Haematologica; 2004 Jun; 89(6):753-4. PubMed ID: 15194546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of aggressive post transplant lymphoproliferative disorder using rituximab.
    O'Dwyer ME; Launder T; Rabkin JM; Nichols CR
    Leuk Lymphoma; 2000 Oct; 39(3-4):411-9. PubMed ID: 11342323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of Epstein-Barr virus associated post-transplant lymphoproliferative disorder with CNS involvement: pathological findings at both biopsy and autopsy.
    Suzuki M; Kosugi I; Terada T; Shirakawa K; Suzuki H; Kono S; Miyajima H
    Neuropathology; 2011 Aug; 31(4):440-5. PubMed ID: 21134001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.